UK Markets closed

Global Opportunity Analysis in the Regenerative Medicine Market to 2030 - A $172.17 Billion Market by 2030

Research and Markets
·3-min read

Dublin, Feb. 15, 2021 (GLOBE NEWSWIRE) -- The "Regenerative Medicine Market by Product, by Material, by Application - Global Opportunity Analysis and Industry Forecast, 2020 - 2030" report has been added to's offering.

The Global Regenerative Medicine Market size is estimated to be USD 13.22 billion in 2019 and is predicted to reach USD 172.17 billion by 2030 with a CAGR of 26.2% from 2020-2030. Regenerative Medicine are used to regenerate, repair, replace or restore tissues and organs damaged by diseases or due to natural ageing. These medicines help in the restoration of normal cell functions and are widely used to treat various degenerative disorders such as cardiovascular disorders, orthopedic disorders and others. Stem cell plays an important role in regenerative medicine as they are capable of proliferating and differentiating into all cell types in an organism, including extra-embryonic tissues.

Increased pipeline of regenerative medicine products along with growing government investments in the research of regenerative medicine are likely to drive the overall regenerative medicine market growth. Also, rising demand for organ transplantation and increasing awareness about use of regenerative medicine therapies in organ transplantation and implementation of the 21st Century Cures Act, a U.S. law enacted by the 114th United States Congress in December 2016 are likely to create growth opportunities in the market.

The other factors such as technological advancement, increased adoption of regenerative medicine, shortage of organs for organ transplantation with involvement of stem cells are expected to promote the market growth. Further, improvements in surgical techniques and untapped market potential are also expected to enhance the growth of regenerative medicine market during the forecast period. However, high cost of treatment and stringent government regulations are expected to hinder the market growth. On the other hand, the increase in research and development activities and clinical trials are expected to create ample opportunity in the regenerative medicine market in the near future.

North America denotes the increased adoption of regenerative medicine and holds the major market share owing to the high disposable income, technological advancement, and increased prevalence of chronic disorders in this region. Also, developed healthcare facilities and infrastructure are also expected to augment the growth of regenerative medicine market in U.S. and Canada.

Asia Pacific is expected to grow rapidly over the forecast period owing to the presence of emerging economies such as China, India, Vietnam among others coupled with increasing accessibility to healthcare facilities.

The regenerative medicine market, which is highly competitive and consists of various market players. Some of the major market players include Athersys, Inc., Stryker Corporation, Zimmer Biomet Holdings, Inc., Medtronic Plc., Organogenesis, Inc. (Advanced Biohealing), U.S. Stem Cell, Inc. (Bioheart, Inc.), Integra Lifesciences Holdings Corporation, Acelity Holdings, Inc., Isto Biologics (Isto Biologics Medical Systems, Inc.), and CryoLife, Inc. among others.

Key Topics Covered:

1. Introduction

2. Market Snapshot, 2019-2030 Million Usd

3. Porter's Five Force Model Analysis

4. Market Dynamics

5. Global Regenerative Medicine Market, by Product Type

6. Global Regenerative Medicine Market, by Material

7. Global Regenerative Medicine Market, by Application

8. Global Regenerative Medicine Market, by Region

9. Company Profiles

  • Allergan

  • Integra Lifesciences

  • Medtronic

  • Cook Biotech Incorporated

  • Baxter

  • Sigma-Aldrich Co.

  • Becton Dickinson and Company

  • smith and nephew Plc

  • Thermo Fisher Scientific

  • Organogenesis Inc.

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood, Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900